Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd R Burmester

Showing results (181-190 of 293) with videos related to

Pageof 30
Sort By:
Arthritis Research & Therapy|June 21, 2018
Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritisVibeke Strand, Laure Gossec, Clare W J Proudfoot, et al.
Lancet (London, England)|January 9, 2013
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trialGerd R Burmester, Ricardo Blanco, Christina Charles-Schoeman, et al.
Rheumatology (Oxford, England)|November 17, 2020
Peripheral blood mononuclear cells are hypomethylated in active rheumatoid arthritis and methylation correlates with disease activityIlka Liebold, Andreas Grützkau, Anika Göckeritz, et al.
Arthritis Research & Therapy|August 14, 2015
Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritisLuisa Lindenberg, Lydia Spengler, Holger Bang, et al.
Annals of the Rheumatic Diseases|May 23, 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 yearsGerd R Burmester, Jacques-Eric Gottenberg, Roberto Caporali, et al.
Annals of the Rheumatic Diseases|June 14, 2020
Bacterial citrullinated epitopes generated by <i>Porphyromonas gingivalis</i> infection-a missing link for ACPA productionMadeleine Jenning, Bianka Marklein, Jimmy Ytterberg, et al.
Arthritis and Rheumatism|August 1, 2009
Improvement in hemoglobin levels in patients with ankylosing spondylitis treated with infliximabJürgen Braun, Désirée van der Heijde, Mittie K Doyle, et al.
Annals of the Rheumatic Diseases|March 24, 2012
Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trialIn-Ho Song, Christian E Althoff, Hildrun Haibel, et al.
Annals of the Rheumatic Diseases|February 9, 2020
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritisAlexandre Sepriano, Andreas Kerschbaumer, Josef S Smolen, et al.
Arthritis Research & Therapy|February 18, 2009
Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patientsKatharina Hanke, Claudia S Brückner, Cornelia Dähnrich, et al.
Pageof 30

Showing results (181-190 of 293) with videos related to

Sort By:
Pageof 30
Arthritis Research & Therapy|June 21, 2018
Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritisVibeke Strand, Laure Gossec, Clare W J Proudfoot, et al.
Lancet (London, England)|January 9, 2013
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trialGerd R Burmester, Ricardo Blanco, Christina Charles-Schoeman, et al.
Rheumatology (Oxford, England)|November 17, 2020
Peripheral blood mononuclear cells are hypomethylated in active rheumatoid arthritis and methylation correlates with disease activityIlka Liebold, Andreas Grützkau, Anika Göckeritz, et al.
Arthritis Research & Therapy|August 14, 2015
Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritisLuisa Lindenberg, Lydia Spengler, Holger Bang, et al.
Annals of the Rheumatic Diseases|May 23, 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 yearsGerd R Burmester, Jacques-Eric Gottenberg, Roberto Caporali, et al.
Annals of the Rheumatic Diseases|June 14, 2020
Bacterial citrullinated epitopes generated by <i>Porphyromonas gingivalis</i> infection-a missing link for ACPA productionMadeleine Jenning, Bianka Marklein, Jimmy Ytterberg, et al.
Arthritis and Rheumatism|August 1, 2009
Improvement in hemoglobin levels in patients with ankylosing spondylitis treated with infliximabJürgen Braun, Désirée van der Heijde, Mittie K Doyle, et al.
Annals of the Rheumatic Diseases|March 24, 2012
Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trialIn-Ho Song, Christian E Althoff, Hildrun Haibel, et al.
Annals of the Rheumatic Diseases|February 9, 2020
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritisAlexandre Sepriano, Andreas Kerschbaumer, Josef S Smolen, et al.
Arthritis Research & Therapy|February 18, 2009
Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patientsKatharina Hanke, Claudia S Brückner, Cornelia Dähnrich, et al.
Pageof 30